Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
17.03
-0.03 (-0.15%)
Mar 31, 2025, 1:15 PM EDT - Market open
Fulgent Genetics Analyst Ratings
Total Analysts
1
Consensus Rating
Hold
Price Target
$16.00
Upside
-6.02%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $22 → $16 | Hold | Maintains | $22 → $16 | -6.02% | Mar 4, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $26 → $22 | Hold | Maintains | $26 → $22 | +29.22% | Nov 11, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $28 → $25 | Hold | Maintains | $28 → $25 | +46.84% | Mar 6, 2024 |
| UBS | UBS | Hold Initiates $35 | Hold | Initiates | $35 | +105.58% | Dec 7, 2023 |
| Piper Sandler | Piper Sandler | Hold Maintains $37 → $28 | Hold | Maintains | $37 → $28 | +64.46% | Oct 16, 2023 |
| Credit Suisse | Credit Suisse | Buy Maintains $50 → $45 | Buy | Maintains | $50 → $45 | +164.32% | Mar 2, 2023 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $65 → $40 | Buy → Hold | Downgrades | $65 → $40 | +134.95% | Dec 8, 2022 |
| Raymond James | Raymond James | Buy Initiates $45 | Buy | Initiates | $45 | +164.32% | Nov 18, 2022 |
| Credit Suisse | Credit Suisse | Buy Maintains $65 → $50 | Buy | Maintains | $65 → $50 | +193.69% | Nov 14, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $70 → $65 | Buy | Maintains | $70 → $65 | +281.79% | Nov 14, 2022 |
| Credit Suisse | Credit Suisse | Buy Initiates $65 | Buy | Initiates | $65 | +281.79% | Aug 25, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $85 → $70 | Buy | Maintains | $85 → $70 | +311.16% | May 16, 2022 |
| Oppenheimer | Oppenheimer | Buy Maintains $141 → $125 | Buy | Maintains | $141 → $125 | +634.21% | Jan 25, 2022 |
| Credit Suisse | Credit Suisse | Sell Maintains $55 → $65 | Sell | Maintains | $55 → $65 | +281.79% | Aug 10, 2021 |
| Piper Sandler | Piper Sandler | Buy Maintains $135 → $140 | Buy | Maintains | $135 → $140 | +722.32% | Mar 5, 2021 |
| Oppenheimer | Oppenheimer | Buy Maintains $75 → $130 | Buy | Maintains | $75 → $130 | +663.58% | Feb 1, 2021 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.